Results 161 to 170 of about 290,212 (305)
Interventional therapies for chronic heart failure: An overview of recent developments
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo +7 more
wiley +1 more source
PAI-1 Inhibition in experimental venous thrombosis. [PDF]
Shaydakov ME +4 more
europepmc +1 more source
Abstract Objective This study aimed to evaluate the utility of left atrial volume and function in uraemic patients using four‐dimensional automatic left atrial quantification (4D auto LAQ) technology. Methods Thirty‐four undialysed uraemic patients (U‐ND group), 60 dialysed uraemic patients (U‐D group), and 32 healthy volunteers (N group) were enrolled
Bing Li, Meihua Chen, Xuning Huang
wiley +1 more source
Hematemesis resulting from mesenteric venous thrombosis: A case report. [PDF]
Shi C, Li Z, Pan L, Song B.
europepmc +1 more source
Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation [PDF]
Antonio D. Pinna +14 more
core +1 more source
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo +10 more
wiley +1 more source
Higher calling: impact of elevation on deep venous thrombosis. [PDF]
Magee AP, Magee GA.
europepmc +1 more source
Splenic artery aneurysms occurring in liver transplant recipients [PDF]
Bronsther, O +3 more
core +1 more source
Abstract Objectives Antiseizure medications (ASMs) can induce the activity of drug‐metabolizing enzymes and drug transporters, including cytochrome P450 (CYP)2C9 and P‐glycoprotein (P‐gp). Our objective was to comparatively assess the effects of ASMs on exposure to clinical CYP2C9 and P‐gp substrates.
Hagar Cohen +4 more
wiley +1 more source
Cerebral venous thrombosis in non-bacterial infections: a systematic review. [PDF]
Medeiros MC +3 more
europepmc +1 more source

